Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_10k.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_ex24-1.htm |
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_ex31-2.htm |
| EX-21.1 - EXHIBIT 21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v335724_ex21-1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Navidea Biopharmaceuticals, Inc.
Dublin, Ohio
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-173752 and 333-184173) and Form S-8 (Nos. 333-05143, 333-119219, 333-130636, 333-130640, 333-153110, 333-158323 and 333-183317) of Navidea Biopharmaceuticals, Inc. of our reports dated March 18, 2013, relating to the consolidated financial statements, and the effectiveness of Navidea Biopharmaceuticals, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
Chicago, Illinois
March 18, 2013